BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26034112)

  • 1. Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience.
    Dreyling M; Ferrero S;
    Haematologica; 2015 Jun; 100(6):706-8. PubMed ID: 26034112
    [No Abstract]   [Full Text] [Related]  

  • 2. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine.
    Sandoval-Sus JD; Sotomayor EM; Shah BD
    Hematol Oncol Stem Cell Ther; 2017 Sep; 10(3):99-115. PubMed ID: 28404221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?
    Ferrero S; Dreyling M;
    Haematologica; 2017 Jul; 102(7):1133-1136. PubMed ID: 28655809
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence and survival trends in mantle cell lymphoma.
    Epperla N; Hamadani M; Fenske TS; Costa LJ
    Br J Haematol; 2018 Jun; 181(5):703-706. PubMed ID: 28444739
    [No Abstract]   [Full Text] [Related]  

  • 6. The modern approach to mantle cell lymphoma.
    Rule S
    Hematol Oncol; 2019 Jun; 37 Suppl 1():66-69. PubMed ID: 31187531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolent mantle cell lymphoma.
    Hsi ED; Martin P
    Leuk Lymphoma; 2014 Apr; 55(4):761-7. PubMed ID: 23927395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mantle Cell Lymphoma-Time to Dismantle the Treatment Paradox.
    Yavorkovsky LL
    JAMA Oncol; 2018 May; 4(5):626-627. PubMed ID: 29494738
    [No Abstract]   [Full Text] [Related]  

  • 9. Mantle Cell Lymphoma: Is It Time for a New Treatment Paradigm?
    Goy A
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1345-1370. PubMed ID: 27888885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage mantle cell lymphoma-a rare entity with special characteristics and needs for treatment.
    Specht L;
    Ann Hematol; 2020 Dec; 99(12):2963-2964. PubMed ID: 32914247
    [No Abstract]   [Full Text] [Related]  

  • 11. Mantle cell lymphoma.
    Birgitta S
    Semin Cancer Biol; 2011 Nov; 21(5):291-2. PubMed ID: 22082693
    [No Abstract]   [Full Text] [Related]  

  • 12. Current regimens and novel agents for mantle cell lymphoma.
    Chen Y; Wang M; Romaguera J
    Br J Haematol; 2014 Oct; 167(1):3-18. PubMed ID: 24974852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolving confusion: the new realities of mantle cell lymphoma.
    O'Connor OA
    Oncology (Williston Park); 2009 Jul; 23(8):690-1. PubMed ID: 19711583
    [No Abstract]   [Full Text] [Related]  

  • 14. Update in the management of mantle cell lymphoma.
    Goy A
    Clin Adv Hematol Oncol; 2013 May; 11(5):297-9. PubMed ID: 23880713
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ten years progression-free survival obtained in a patient with mantle cell lymphoma].
    Wysokińska E; Kolak A; Starosławska E; Kieszko D; Kamińska M; Surdyka D; Mocarska A; Burdan F
    Pol Merkur Lekarski; 2015 May; 38(227):280-2. PubMed ID: 26039024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle cell lymphoma.
    Friedberg JW
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):131-2. PubMed ID: 22687448
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mantle cell lymphoma: case report].
    Méhes L; Telek B; Udvardy M; Schlammadinger A; és Rejto L
    Orv Hetil; 2008 Aug; 149(31):1471-4. PubMed ID: 18632508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
    Thieblemont C; Antal D; Lacotte-Thierry L; Delwail V; Espinouse D; Michallet AS; Traulle C; Bouafia-Sauvy F; Giraud C; Salles G; Guilhot F; Coiffier B
    Cancer; 2005 Oct; 104(7):1434-41. PubMed ID: 16104036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression.
    Vogt N; Klapper W
    Histopathology; 2013 Jan; 62(2):334-42. PubMed ID: 23240716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of mantle cell lymphoma.
    Meusers P; Hense J
    Ann Hematol; 1999 Nov; 78(11):485-94. PubMed ID: 10602892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.